Biallelic SMARCB1 inactivation has been detected in a multitude of different tumour types and at high frequency in rhabdoid tumours (reviewed by Roberts and Biegel, 2009; Hollmann and Hornick 2011; Masliah-Planchon et al. 2015). The gene discussed is SMARCB1; the disease is neoplasm.